These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14678586)

  • 1. Ethnic variation of the P53 codon 72 polymorphism, HPV persistence, and cervical cancer risk.
    Inserra P; Abrahamsen M; Papenfuss M; Giuliano AR
    Int J STD AIDS; 2003 Dec; 14(12):800-4. PubMed ID: 14678586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 polymorphism, HPV infection, and risk of cervical cancer.
    Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
    Bhattacharya P; Sengupta S
    Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy.
    Comar M; Molin GD; Guaschino S; Campello C
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):210-4. PubMed ID: 15140517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
    Li CY; Liu JH; Huang BJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer.
    Haws AL; Woeber S; Gomez M; Garza N; Gomez Y; Rady P; He Q; Zhang L; Grady JJ; McCormick JB; Fisher-Hoch SP; Tyring SK
    J Med Virol; 2005 Oct; 77(2):265-72. PubMed ID: 16121365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency.
    Govan VA; Loubser S; Saleh D; Hoffman M; Williamson AL
    Int J Immunogenet; 2007 Jun; 34(3):213-7. PubMed ID: 17504512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China.
    Li T; Lu ZM; Guo M; Wu QJ; Chen KN; Xing HP; Mei Q; Ke Y
    Cancer; 2002 Dec; 95(12):2571-6. PubMed ID: 12467072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer.
    Dokianakis DN; Spandidos DA
    Mol Cell Biol Res Commun; 2000 Feb; 3(2):111-4. PubMed ID: 10775508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors for cervico-uterine cancer associated to HPV: p53 codon 72 polymorphism in women attending hospital care].
    Sifuentes Alvarez A; Reyes Romero M
    Ginecol Obstet Mex; 2003 Jan; 71():12-5. PubMed ID: 12708345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymorphism in codon 72 of the p53 gene and cervico-uterine cancer risk in Mexico].
    Suárez-Rincón AE; Morán-Moguel MC; Montoya-Fuentes H; Gallegos-Arreola MP; Sánchez-Corona J
    Ginecol Obstet Mex; 2002 Jul; 70():344-8. PubMed ID: 12221910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
    Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
    Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women.
    Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D
    Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection.
    Minaguchi T; Kanamori Y; Matsushima M; Yoshikawa H; Taketani Y; Nakamura Y
    Cancer Res; 1998 Oct; 58(20):4585-6. PubMed ID: 9788606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
    Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
    Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
    Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohort.
    Pantelis A; Pantelis D; Ruemmele P; Hartmann A; Hofstaedter F; Buettner R; Bootz F; Stoehr R
    Oncol Rep; 2007 May; 17(5):1243-8. PubMed ID: 17390072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 codon 72 polymorphism and HPV status in lung cancer.
    Buyru N; Altinisik J; Isin M; Dalay N
    Med Sci Monit; 2008 Sep; 14(9):CR493-7. PubMed ID: 18758421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
    Chatterjee K; Williamson AL; Hoffman M; Dandara C
    J Med Virol; 2011 Apr; 83(4):630-6. PubMed ID: 21328377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma.
    Giuliani L; Jaxmar T; Casadio C; Gariglio M; Manna A; D'Antonio D; Syrjanen K; Favalli C; Ciotti M
    Lung Cancer; 2007 Sep; 57(3):273-81. PubMed ID: 17400331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.